The potential therapeutic role of Lisinopril in augmenting the striatal neuroplasticity via the striatal ACE2/Ang1-7/MAS receptor axis in 3-nitropropionic acid-induced Huntington's disease in rats: shifting paradigms in Huntington's disease treatment
Abstract Background The exact pathogenesis of Huntington's disease (HD) remains unclear. However, mitochondrial dysfunction and oxidative stress are supposed to play a significant role. The objective of this study was to examine the possible neuroprotective effect of Lisinopril (Lisino) in a 3-...
Saved in:
Main Authors: | Hanaa Wanas (Author), Mostafa Adel Rabie (Author), Basma Emad Aboulhoda (Author), Nagwa Mahmoud Ramadan (Author), Sahar Abdelwahab (Author), Sara Sayed Kadry Abdallah (Author), Eid Nassar Ali (Author), Leyan Nasruddeen Khayruddeen (Author), Yasir Hassan Elhassan (Author), Hadel Mahroos Alghabban (Author), Shaimaa Mohamed Abdelsalam (Author), Amira Karam Khalifa (Author) |
---|---|
Format: | Book |
Published: |
SpringerOpen,
2024-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Huntington's Disease and Striatal Signaling
by: Emmanuel eRoze, et al.
Published: (2011) -
BACHD Mice Recapitulate the Striatal Parvalbuminergic Interneuron Loss Found in Huntington's Disease
by: Vyshnavi Rallapalle, et al.
Published: (2021) -
3D Imaging of Striatal Transplants in a Small Animal Model of Huntington's Disease
by: Elisabeth Schültke, et al.
Published: (2023) -
Selective Sparing of Striatal Interneurons after Poly (ADP-Ribose) Polymerase 1 Inhibition in the R6/2 Mouse Model of Huntington's Disease
by: Emanuela Paldino, et al.
Published: (2017) -
Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Protects Striatal Cells and Improves Motor Function in Huntington's Disease Models: Role of PAC1 Receptor
by: Irene Solés-Tarrés, et al.
Published: (2022)